Explore more publications!
Health Update Bahamas
Got News to Share?

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 20, 2025

Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting
November 20, 2025

Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting

Indeterminate GlobeNewswire
Catheter Precision Announces Successful LockeT Launch in South Africa
November 20, 2025

Catheter Precision Announces Successful LockeT Launch in South Africa

Indeterminate GlobeNewswire
Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025
November 20, 2025

Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025

Indeterminate GlobeNewswire
Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health
November 20, 2025

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

Indeterminate GlobeNewswire
Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
November 20, 2025

Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™

Indeterminate GlobeNewswire
Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update
November 20, 2025

Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
November 20, 2025

Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030

Indeterminate GlobeNewswire
Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate
November 20, 2025

Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate

Indeterminate GlobeNewswire
USA Pharma Unveils NowBurnMax: A Revolutionary Weight Loss Solution
November 20, 2025

USA Pharma Unveils NowBurnMax: A Revolutionary Weight Loss Solution

Indeterminate GlobeNewswire
EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU 
November 20, 2025

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU 

Indeterminate GlobeNewswire
Avis aux médias: L’Hôpital Shriners pour enfants Canada ouvre ses portes au public le 29 novembre pour souligner son 100e anniversaire
November 20, 2025

Avis aux médias: L’Hôpital Shriners pour enfants Canada ouvre ses portes au public le 29 novembre pour souligner son 100e anniversaire

Indeterminate GlobeNewswire
Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference
November 20, 2025

Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference

Indeterminate GlobeNewswire
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
November 20, 2025

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Indeterminate GlobeNewswire
Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
November 20, 2025

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 20, 2025

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
November 20, 2025

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Indeterminate GlobeNewswire
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
November 20, 2025

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

Indeterminate GlobeNewswire
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
November 20, 2025

Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets

Indeterminate GlobeNewswire
Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration
November 20, 2025

Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration

Indeterminate GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences
November 20, 2025

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions